These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 12878353)
1. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Le Friec G; Laupèze B; Fardel O; Sebti Y; Pangault C; Guilloux V; Beauplet A; Fauchet R; Amiot L Hum Immunol; 2003 Aug; 64(8):752-61. PubMed ID: 12878353 [TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417 [TBL] [Abstract][Full Text] [Related]
3. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. Le Friec G; Gros F; Sebti Y; Guilloux V; Pangault C; Fauchet R; Amiot L J Leukoc Biol; 2004 Dec; 76(6):1125-33. PubMed ID: 15331623 [TBL] [Abstract][Full Text] [Related]
4. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Horuzsko A; Lenfant F; Munn DH; Mellor AL Int Immunol; 2001 Mar; 13(3):385-94. PubMed ID: 11222508 [TBL] [Abstract][Full Text] [Related]
5. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. López AS; Alegre E; LeMaoult J; Carosella E; González A Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253 [TBL] [Abstract][Full Text] [Related]
6. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j. Morel E; Bellón T J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926 [TBL] [Abstract][Full Text] [Related]
7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415 [TBL] [Abstract][Full Text] [Related]
8. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088 [TBL] [Abstract][Full Text] [Related]
10. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976 [TBL] [Abstract][Full Text] [Related]
11. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Weiss EH; Dichgans J; Lochmuller H; Hohlfeld R; Melms A; Weller M Brain; 2003 Jan; 126(Pt 1):176-85. PubMed ID: 12477705 [TBL] [Abstract][Full Text] [Related]
12. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028 [TBL] [Abstract][Full Text] [Related]
13. HLA-G modulates immune responses by diverse receptor interactions. Hofmeister V; Weiss EH Semin Cancer Biol; 2003 Oct; 13(5):317-23. PubMed ID: 14708711 [TBL] [Abstract][Full Text] [Related]
14. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2. Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625 [TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways. Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119 [TBL] [Abstract][Full Text] [Related]
16. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Aractingi S; Briand N; Le Danff C; Viguier M; Bachelez H; Michel L; Dubertret L; Carosella ED Am J Pathol; 2001 Jul; 159(1):71-7. PubMed ID: 11438456 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells bearing HLA-G inhibit T-Cell activation in type 1 diabetes. Abediankenari S; Eslami MB; Sarrafnejad A; Mohseni M; Larijani B Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):1-7. PubMed ID: 17303922 [TBL] [Abstract][Full Text] [Related]
18. Soluble HLA-G molecules are increased in lymphoproliferative disorders. Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneous expression of HLA-G1, -G2, -G5, -G6, and -G7 in myeloid and plasmacytoid dendritic cells isolated from umbilical cord blood. Román A; Rodríguez M; Herraiz MA; Jordá J; Cervera I; Peñaloza J; Vidart JA; Martinez-Laso J Hum Immunol; 2009 Feb; 70(2):104-9. PubMed ID: 19135113 [TBL] [Abstract][Full Text] [Related]
20. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Le Rond S; Le Maoult J; Créput C; Menier C; Deschamps M; Le Friec G; Amiot L; Durrbach A; Dausset J; Carosella ED; Rouas-Freiss N Eur J Immunol; 2004 Mar; 34(3):649-660. PubMed ID: 14991594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]